Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks

Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks

Abstract Background Generic drugs may help to support antiretroviral treatment. We want to assess the efficacy and safety at 24 weeks of the change of coformulated (abacavir + lamivudine + dolutegravir) to (abacavir + lamivudine) coformulated as a generic pharmaceutical specialty + dolutegravir. Met...

Full description

Saved in:
Bibliographic Details
Main Authors: Julián Olalla (Author), Javier Pérez-Stachowski (Author), Begoña Tortajada (Author), Alfonso Del Arco (Author), Efrén Márquez (Author), Javier De la Torre (Author), Miriam Nieto (Author), José María García de Lomas (Author), José Luis Prada (Author), Javier García-Alegría (Author)
Format: Book
Published: BMC, 2018-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items